Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 99.
202. lappuse
... less than a 2 - fold dif- ference in median lethal dose ( LD50 ) and median effective dose ( ED50 ) val- ues , or have less than a 2 - fold dif- ference in the minimum toxic con- centrations and minimum effective concentrations in the ...
... less than a 2 - fold dif- ference in median lethal dose ( LD50 ) and median effective dose ( ED50 ) val- ues , or have less than a 2 - fold dif- ference in the minimum toxic con- centrations and minimum effective concentrations in the ...
325. lappuse
... less . ( 4 ) Polymyxin B. The term " unit " ap- plied to polymyxin B means the poly- myxin activity ( potency ) contained in 0.1274 microgram of the polymyxin B master standard when dried for 3 hours at 60 ° C. and a pressure of 5 ...
... less . ( 4 ) Polymyxin B. The term " unit " ap- plied to polymyxin B means the poly- myxin activity ( potency ) contained in 0.1274 microgram of the polymyxin B master standard when dried for 3 hours at 60 ° C. and a pressure of 5 ...
326. lappuse
... less . term ( 12 ) Amphotericin B. The " microgram " applied to amphotericin B means the amphotericin B activity ( potency ) contained in 1.014 micrograms of the amphotericin B master standard when dried for 3 hours at 60 ° C. and a ...
... less . term ( 12 ) Amphotericin B. The " microgram " applied to amphotericin B means the amphotericin B activity ( potency ) contained in 1.014 micrograms of the amphotericin B master standard when dried for 3 hours at 60 ° C. and a ...
327. lappuse
... less . term ( 32 ) Dactinomycin . The " microgram " applied to dactinomycin means the dactinomycin activity ( po- tency ) contained in 1.000 microgram of the dactinomycin master standard when dried for 3 hours at 60 ° C. and a pressure ...
... less . term ( 32 ) Dactinomycin . The " microgram " applied to dactinomycin means the dactinomycin activity ( po- tency ) contained in 1.000 microgram of the dactinomycin master standard when dried for 3 hours at 60 ° C. and a pressure ...
332. lappuse
... less , a representative sample consisting of not more than 100 units shall be col- lected by taking single units at ... less , the sample is 100 units , taken in approximately equal amounts from each container . ( 2 ) For batches of ...
... less , a representative sample consisting of not more than 100 units shall be col- lected by taking single units at ... less , the sample is 100 units , taken in approximately equal amounts from each container . ( 2 ) For batches of ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning